Slawin KM - Search Results

1

Survivin expression is associated with features of biologically aggressive prostate carcinoma.

Shariat SF, Lotan Y, Saboorian H, Khoddami SM, Roehrborn CG, Slawin KM, Ashfaq R. Shariat SF, et al. Among authors: slawin km. Cancer. 2004 Feb 15;100(4):751-7. doi: 10.1002/cncr.20039. Cancer. 2004. PMID: 14770431 Free article.

2

Association of pre- and postoperative plasma levels of transforming growth factor beta(1) and interleukin 6 and its soluble receptor with prostate cancer progression.

Shariat SF, Kattan MW, Traxel E, Andrews B, Zhu K, Wheeler TM, Slawin KM. Shariat SF, et al. Among authors: slawin km. Clin Cancer Res. 2004 Mar 15;10(6):1992-9. doi: 10.1158/1078-0432.ccr-0768-03. Clin Cancer Res. 2004. PMID: 15041717

3

Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia.

Shariat SF, Ashfaq R, Roehrborn CG, Slawin KM, Lotan Y. Shariat SF, et al. Among authors: slawin km. J Urol. 2005 Nov;174(5):2046-50. doi: 10.1097/01.ju.0000176459.79180.d1. J Urol. 2005. PMID: 16217391

4

Plasminogen activation inhibitor-1 improves the predictive accuracy of prostate cancer nomograms.

Shariat SF, Park S, Trinh QD, Roehrborn CG, Slawin KM, Karakiewicz PI. Shariat SF, et al. Among authors: slawin km. J Urol. 2007 Oct;178(4 Pt 1):1229-36; discussion 1236-7. doi: 10.1016/j.juro.2007.05.161. Epub 2007 Aug 14. J Urol. 2007. PMID: 17698116 Clinical Trial.

5

Preoperative plasma HER2 and epidermal growth factor receptor for staging and prognostication in patients with clinically localized prostate cancer.

Shariat SF, Bensalah K, Karam JA, Roehrborn CG, Gallina A, Lotan Y, Slawin KM, Karakiewicz PI. Shariat SF, et al. Among authors: slawin km. Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5377-84. doi: 10.1158/1078-0432.CCR-07-0330. Clin Cancer Res. 2007. PMID: 17875766

6

Herbal/hormonal dietary supplement possibly associated with prostate cancer progression.

Shariat SF, Lamb DJ, Iyengar RG, Roehrborn CG, Slawin KM. Shariat SF, et al. Among authors: slawin km. Clin Cancer Res. 2008 Jan 15;14(2):607-11. doi: 10.1158/1078-0432.CCR-07-1576. Clin Cancer Res. 2008. PMID: 18223237

7

Use of preoperative plasma endoglin for prediction of lymph node metastasis in patients with clinically localized prostate cancer.

Karam JA, Svatek RS, Karakiewicz PI, Gallina A, Roehrborn CG, Slawin KM, Shariat SF. Karam JA, et al. Among authors: slawin km. Clin Cancer Res. 2008 Mar 1;14(5):1418-22. doi: 10.1158/1078-0432.CCR-07-0901. Clin Cancer Res. 2008. PMID: 18316564

8

Preoperative plasma endoglin levels predict biochemical progression after radical prostatectomy.

Svatek RS, Karam JA, Roehrborn CG, Karakiewicz PI, Slawin KM, Shariat SF. Svatek RS, et al. Among authors: slawin km. Clin Cancer Res. 2008 Jun 1;14(11):3362-6. doi: 10.1158/1078-0432.CCR-07-4707. Clin Cancer Res. 2008. PMID: 18519764

9

Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers.

Shariat SF, Karam JA, Walz J, Roehrborn CG, Montorsi F, Margulis V, Saad F, Slawin KM, Karakiewicz PI. Shariat SF, et al. Among authors: slawin km. Clin Cancer Res. 2008 Jun 15;14(12):3785-91. doi: 10.1158/1078-0432.CCR-07-4969. Clin Cancer Res. 2008. PMID: 18559597

10

Biochemical staging of prostate cancer.

Canto EI, Shariat SF, Slawin KM. Canto EI, et al. Among authors: slawin km. Urol Clin North Am. 2003 May;30(2):263-77. doi: 10.1016/s0094-0143(02)00183-0. Urol Clin North Am. 2003. PMID: 12735503 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters